LSC Webinars CELL All
-
Enhancing Viral Vector Sterile Filtration: Process Efficiency And GMP Alignment
11/4/2025
Explore filtration strategies that improve viral vector yield and quality, with insights on AAV and lentivirus workflows, plus practical guidance for implementing PUPSIT in line with requirements.
-
How To Select The Right Bioanalysis CRO For Your Program
11/3/2025
The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?
-
Developing Your Risk-Based Approach To Single-Use System Integrity
10/29/2025
Explore how a holistic approach to single-use system integrity can strengthen contamination control, improve operational efficiency, and meet evolving regulatory expectations in manufacturing.
-
Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes
10/28/2025
Explore how salt-active endonucleases overcome DNA clearance challenges in viral vector purification by digesting down to 3–5 nucleotides and performing reliably in high-salt conditions.
-
Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation
10/22/2025
Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.
-
Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches
10/22/2025
Learn how genome engineering and iPSCs are being used to overcome the critical challenges of durability and host immune clearance in both clinical and preclinical settings for allogeneic cell therapies.
-
In-Line PAT Solutions For cGMP Environments
10/21/2025
Learn how real-time monitoring and PAT platforms can streamline bioprocessing, reduce testing delays, and improve decision-making across upstream and downstream workflows.
-
Development Of An Off-The-Shelf γδ T-Cell Platform
10/20/2025
Learn how γδ T cells are being engineered into scalable, off-the-shelf therapies with enhanced safety and potency, as well as discover strategies to overcome immunological barriers.
-
Evolving Gene Editing For Rare Disease Drug Development
10/9/2025
Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.
-
Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing
10/9/2025
Discover how effective cell banking and scale-up strategies can reduce risk and cost in advanced therapy manufacturing. Learn practical ways to meet increasing cell and exosome quantity needs.